
President Biden came into office in a strong position on health care, but broader strategic mistakes and limited ambitions are restricting what is possible even at this early stage of his term. Two consequential changes—expanded Affordable Care Act subsidies and prescription drug price controls—might still get approved by Congress, but even their enactment would fall short of the hopes and expectations of his party’s most active supporters.
Want to see more of The Dispatch in Google search?
Add Us as a Preferred Source



